Free Trial

Biotricity (BTCY) Competitors

Biotricity logo
$0.42 -0.08 (-16.00%)
As of 04/17/2025 02:34 PM Eastern

BTCY vs. OM, TELA, APYX, DXR, MODD, BDMD, SPAI, MDAI, FEMY, and POCI

Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Outset Medical (OM), TELA Bio (TELA), Apyx Medical (APYX), Daxor (DXR), Modular Medical (MODD), Baird Medical Investment (BDMD), Safe Pro Group Inc. Common Stock (SPAI), Spectral AI (MDAI), Femasys (FEMY), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

Biotricity vs.

Outset Medical (NASDAQ:OM) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

3.9% of Biotricity shares are held by institutional investors. 4.1% of Outset Medical shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Biotricity has lower revenue, but higher earnings than Outset Medical. Biotricity is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$113.69M0.35-$172.80M-$37.18-0.30
Biotricity$12.06M0.87-$14.09M-$1.08-0.39

Outset Medical presently has a consensus target price of $35.00, suggesting a potential upside of 217.89%. Given Outset Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Outset Medical is more favorable than Biotricity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Outset Medical had 2 more articles in the media than Biotricity. MarketBeat recorded 2 mentions for Outset Medical and 0 mentions for Biotricity. Biotricity's average media sentiment score of 0.00 beat Outset Medical's score of -0.19 indicating that Biotricity is being referred to more favorably in the news media.

Company Overall Sentiment
Outset Medical Neutral
Biotricity Neutral

Outset Medical received 24 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 38.10% of users gave Outset Medical an outperform vote while only 0.00% of users gave Biotricity an outperform vote.

CompanyUnderperformOutperform
Outset MedicalOutperform Votes
24
38.10%
Underperform Votes
39
61.90%
BiotricityOutperform Votes
No Votes
Underperform Votes
2
100.00%

Biotricity has a net margin of -80.42% compared to Outset Medical's net margin of -112.57%. Biotricity's return on equity of 0.00% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-112.57% -175.64% -38.61%
Biotricity -80.42%N/A -188.47%

Outset Medical has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Summary

Outset Medical and Biotricity tied by winning 9 of the 18 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTCY vs. The Competition

MetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$10.46M$4.04B$5.30B$7.35B
Dividend YieldN/A39.51%5.12%4.30%
P/E Ratio-0.3927.6821.8217.80
Price / Sales0.8747.06379.9697.74
Price / CashN/A51.0838.2634.64
Price / Book-0.325.816.443.98
Net Income-$14.09M$67.09M$3.21B$247.73M
7 Day Performance0.19%1.97%2.87%1.81%
1 Month Performance0.12%-4.84%-8.64%-6.96%
1 Year Performance-71.62%14.47%11.47%1.30%

Biotricity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTCY
Biotricity
N/A$0.42
-16.0%
N/A-71.6%$10.46M$12.06M-0.3940
OM
Outset Medical
1.1071 of 5 stars
$11.38
+2.9%
$35.00
+207.6%
-67.4%$40.91M$113.69M-4.59520
TELA
TELA Bio
1.967 of 5 stars
$1.00
-1.0%
$7.25
+625.0%
-81.4%$39.39M$69.30M-0.59120Short Interest ↑
APYX
Apyx Medical
1.2704 of 5 stars
$1.02
-4.7%
N/A-28.3%$38.55M$48.10M-1.23270
DXR
Daxor
4.0225 of 5 stars
$7.49
-5.8%
$25.00
+233.8%
-23.9%$36.23M$2.13M0.0037Short Interest ↓
News Coverage
MODD
Modular Medical
0.7053 of 5 stars
$0.88
-1.3%
N/A-48.1%$35.79MN/A-1.6620Short Interest ↑
Negative News
BDMD
Baird Medical Investment
N/A$5.41
flat
N/AN/A$35.62M$33.05M0.00N/AGap Up
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.12
-4.5%
N/AN/A$32.17M$2.17M0.0011
MDAI
Spectral AI
2.1872 of 5 stars
$1.24
-0.8%
$4.75
+283.1%
-34.4%$31.39M$29.58M-1.9183Short Interest ↑
FEMY
Femasys
1.9406 of 5 stars
$1.15
+0.4%
$11.50
+904.4%
-5.3%$31.09M$1.63M-1.4130
POCI
Precision Optics
0.9529 of 5 stars
$3.95
-2.2%
N/A-25.4%$30.17M$18.68M-6.1780Short Interest ↓
Gap Down

Related Companies and Tools


This page (NASDAQ:BTCY) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners